Cargando…
Survival analysis of factors affecting the timing of COVID-19 non-pharmaceutical interventions by U.S. universities
BACKGROUND: During March of 2020 the Centers for Disease Control and Prevention (CDC) announced non-pharmaceutical intervention (NPI) guidance as the primary mitigation strategy against growing COVID-19 community spread due to the absence of a vaccine or effective treatment at that time. CDC guidanc...
Autores principales: | Cevasco, Kevin E., Roess, Amira A., North, Hayley M., Zeitoun, Sheryne A., Wofford, Rachel N., Matulis, Graham A., Gregory, Abigail F., Hassan, Maha H., Abdo, Aya D., von Fricken, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562371/ https://www.ncbi.nlm.nih.gov/pubmed/34727895 http://dx.doi.org/10.1186/s12889-021-12035-6 |
Ejemplares similares
-
COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across U.S. universities, March 2020
por: Cevasco, Kevin E., et al.
Publicado: (2020) -
Adaptation and Utilization of a Postmarket Evaluation Model for Digital Contact Tracing Mobile Health Tools in the United States: Observational Cross-sectional Study
por: Cevasco, Kevin E, et al.
Publicado: (2023) -
Elevated Risk of Carrying Gentamicin-Resistant Escherichia coli among U.S. Poultry Workers
por: Price, Lance B., et al.
Publicado: (2007) -
The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist
por: Costantino, Ryan C.
Publicado: (2021) -
Predictors of loss due to pharmaceutical fraud: evidence from the U.S.
por: Timofeyev, Yuriy, et al.
Publicado: (2022)